On The Pen: The Weekly Dose
Zepbound Single Dose Vials Approved!
In the largest move since approving Tirzepatide for chronic weight management in November of 2023, the FDA has posted the approval of a single-dose vial presentation of Zepbound. With the complexity of manufacturing the current single-dose pens, single dose vial presentations could prove to be an answer to increasing manufacturing shortages of Tirzepatide for both type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). The FDA approved the single-dose vials of Mounjaro in July of 2023, but Eli Lilly has elected to offer that presentation in x-US markets only.
https://www.onthepen.com/post/zepbound-single-dose-vials-approved-by-fda
📲 Media Inquiries MounjaroMan@gmail.com
Amazon Shop:
https://www.amazon.com/shop/manonthemounjaroonthepen
📼 PLAYLISTS:
🖊️ ON THE PEN LIVES:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
🚨📰 ALL THE LATEST MOUNJARO NEWS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
Venmo: OnThePen
Ca$h App: ManOnMounjaro
BECOME A MEMBER:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
SOCIAL LINKS
https://www.tiktok.com/@manonthemounjaro
https://twitter.com/ManOnMounjaro
https://instagram.com/manonthemounjaro
https://facebook.com/manonthemounjaro
📲 Contact Me: MounjaroMan@gmail.com
📼 PLAYLISTS:
🖊️ ON THE PEN LIVES:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
🚨📰 ALL THE LATEST MOUNJARO NEWS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.
In the largest move since approving Tirzepatide for chronic weight management in November of 2023, the FDA has posted the approval of a single-dose vial presentation of Zepbound. With the complexity of manufacturing the current single-dose pens, single dose vial presentations could prove to be an answer to increasing manufacturing shortages of Tirzepatide for both type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). The FDA approved the single-dose vials of Mounjaro in July of 2023, but Eli Lilly has elected to offer that presentation in x-US markets only.
https://www.onthepen.com/post/zepbound-single-dose-vials-approved-by-fda
📲 Media Inquiries MounjaroMan@gmail.com
Amazon Shop:
https://www.amazon.com/shop/manonthemounjaroonthepen
📼 PLAYLISTS:
🖊️ ON THE PEN LIVES:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
🚨📰 ALL THE LATEST MOUNJARO NEWS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
Venmo: OnThePen
Ca$h App: ManOnMounjaro
BECOME A MEMBER:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
SOCIAL LINKS
https://www.tiktok.com/@manonthemounjaro
https://twitter.com/ManOnMounjaro
https://instagram.com/manonthemounjaro
https://facebook.com/manonthemounjaro
📲 Contact Me: MounjaroMan@gmail.com
📼 PLAYLISTS:
🖊️ ON THE PEN LIVES:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
🚨📰 ALL THE LATEST MOUNJARO NEWS:
https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.